Associated Papers
The prevalence of pathogenic variants in the BMPR2 gene in patients with the idiopathic pulmonary arterial hypertension in the Russian population: sequencing data and meta-analysis.
Okhrimenko G et al.
Respiratory Research, 2025
40229839 (PubMed )
Supplement: 12931_2025_3214_MOESM2_ESM.xlsx › Assessment_
Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar.
Eichstaedt CA et al.
Human Mutation, 2025
Adaptation of ACMG/AMP guidelines for clinical classification of BMPR2 variants in Pulmonary Arterial Hypertension resolves variants of unclear pathogenicity in ClinVar.
Eichstaedt CA et al.
Medrxiv : the Preprint Server for Health Sciences, 2024
Type II BMP and activin receptors BMPR2 and ACVR2A share a conserved mode of growth factor recognition.
Chu KY et al.
The Journal of Biological Chemistry, 2022
Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10.
Guo J et al.
Nature Communications, 2022
Molecular genetic framework underlying pulmonary arterial hypertension.
Southgate L et al.
Nature Reviews. Cardiology, 2020
New pathogenic variant of BMPR2 in pulmonary arterial hypertension.
Yang X et al.
Cardiology in the Young, 2019
Evolutionary conservation and mutational spectrum of BMPR2 gene.
Wong WK et al.
Gene, 2006
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD et al.
Human Mutation, 2006
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease.
Roberts KE et al.
The European Respiratory Journal, 2004
Select a paper to view details